Abstract

Although bone and joint manifestations are common in children with cystic fibrosis, they have received little attention in adults. As compared to healthy individuals, bone mineral density is low, even with calcium intakes greater than 1500 mg/d. Nevertheless, calcium and phosphate levels in blood and urine are often normal, and vitamin D levels vary. Short stature with a low body mass index and central hy-pogonadism are the rule in these patients. Fractures and kyphosis are often reported. Cystic fibrosis arthropathy occurs in 2 to 8,5% of patients. Arthritis develops, and there may be skin eruptions. Nonsteroidal anti-inflammatory drug therapy is effective. Hypertrophic osteo-arthropathy associated with respiratory failure is present in 2 to 7% of patients. Rheumatoid arthritis, spondylo-arthropathies, sarcoido-sis, and amyloidosis have been reported in association with cystic fibrosis. Knee pain due to patellofemoral syndrome, quinolone-induced arthropathy, and mechanical back pain have been described. Rheumatoid factor titers are higher than in healthy controls, particularly in patients with episodic arthritis. No data are available on anti-perinuclear factor or antikeratin antibody titers. Tests for antinuclear antibody are usually negative. Circulating immune complex levels and antibodies to heat shock proteins may be elevated. Antineutrophil cytoplasmic antibody of the BPI or AZ type has been reported, often in high titers (up to 40%).

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.